Home / Cabergoline / Germany
DE ATC N04BC06 · updated 2 Nov 2026
Cabergoline shortage in Germany
Is there a Cabergoline shortage in Germany?
Yes. As of 2 Nov 2026, 4 Cabergoline products are reported short in Germany, the first since 1 Jun 2026. The company estimate for the return is 15 Dec 2026. Main reason: active ingredient shortage.
Also short in Spain, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Cabaseril 1 mg | Pfizer Pharma GmbH | 1 Jun 2026 | 15 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Cabaseril 1 mg | Pfizer Pharma GmbH | 1 Jun 2026 | 15 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Cabaseril 2 mg | Pfizer Pharma GmbH | 1 Jun 2026 | 15 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
| DE | Cabaseril 2 mg | Pfizer Pharma GmbH | 1 Jun 2026 | 15 Dec 2026 | Active ingredient shortage Probleme beim Wirkstoffhersteller |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.